BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 18683883)

  • 1. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
    Nonzee NJ; Dandade NA; Patel U; Markossian T; Agulnik M; Argiris A; Patel JD; Kern RC; Munshi HG; Calhoun EA; Bennett CL
    Cancer; 2008 Sep; 113(6):1446-52. PubMed ID: 18683883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
    Elting LS; Cooksley CD; Chambers MS; Garden AS
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
    Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P
    Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.
    Epstein JB; Beaumont JL; Gwede CK; Murphy B; Garden AS; Meredith R; Le QT; Brizel D; Isitt J; Cella D
    Cancer; 2007 May; 109(9):1914-22. PubMed ID: 17377917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy.
    Murphy BA; Beaumont JL; Isitt J; Garden AS; Gwede CK; Trotti AM; Meredith RF; Epstein JB; Le QT; Brizel DM; Bellm LA; Wells N; Cella D
    J Pain Symptom Manage; 2009 Oct; 38(4):522-32. PubMed ID: 19608377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The problem of radiogenic and chemotherapy-induced mucositis of the mouth and and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinomas of the head-/neck area. Heidelberg experiences].
    Dietz A; Nollert J; Maier H; Rudat V; Flentje M
    HNO; 1995 Jul; 43(7):403-13. PubMed ID: 7545657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer.
    Rashad UM; Al-Gezawy SM; El-Gezawy E; Azzaz AN
    J Laryngol Otol; 2009 Feb; 123(2):223-8. PubMed ID: 18485252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
    Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands.
    Pompen M; Gok M; Novák A; van Wuijtswinkel R; Biesma B; Schramel F; Stigt J; Smit H; Postmus P
    Lung Cancer; 2009 Apr; 64(1):110-6. PubMed ID: 18805601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.
    Bennett CL; Calhoun EA
    Oncologist; 2007 Apr; 12(4):478-83. PubMed ID: 17470690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic non-small cell lung cancer: costs associated with disease progression.
    Fox KM; Brooks JM; Kim J
    Am J Manag Care; 2008 Sep; 14(9):565-71. PubMed ID: 18778171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma.
    Vera-Llonch M; Oster G; Hagiwara M; Sonis S
    Cancer; 2006 Jan; 106(2):329-36. PubMed ID: 16342066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral mucositis.
    Sonis ST
    Anticancer Drugs; 2011 Aug; 22(7):607-12. PubMed ID: 21709615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy.
    Murphy BA
    J Support Oncol; 2007 Oct; 5(9 Suppl 4):13-21. PubMed ID: 18046994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis.
    Penel N; Lefebvre JL; Cazin JL; Clisant S; Neu JC; Dervaux B; Yazdanpanah Y
    Int J Oral Maxillofac Surg; 2008 Feb; 37(2):135-9. PubMed ID: 18022348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary lung cancer after treatment of head and neck cancer without lymph node metastasis: is there a role for autofluorescence bronchoscopy?
    Lee P; de Bree R; Brokx HA; Leemans CR; Postmus PE; Sutedja TG
    Lung Cancer; 2008 Dec; 62(3):309-15. PubMed ID: 18486989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs for 5-year lung cancer survivors in a tertiary care hospital in South Korea.
    Park YS; Kim SH; Park SK; Park BJ; Kim YT; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Shim YS; Yang SC
    Lung Cancer; 2010 May; 68(2):299-304. PubMed ID: 19646776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.